Addressing supportive care issues can require significant effort. With PGxOncoTM testing,
physicians can be well-prepared in managing many facets of patient care.
Pain Management Drugs
PGxOnco™ testing can guide
optimum treatment of
cancer-related pain for both
current patients and survivors.
When anxiety, fear or depression
emerge, medication may be
indicated. PGxOnco™ can enable
faster relief by reducing trial-and-error
prescribing and dosage titration.
Chemotherapy-induced nausea and vomiting are major concerns associated with cancer treatment. PGxOnco™ testing can help reduce these side effects and improve quality of life by optimizing drug therapy.
Efficacy and tolerance of chemotherapeutic drugs varies widely. A key contributing factor is genetics. For example, 5-FU, a commonly used chemotherapeutic is often poorly metabolized by patients with certain DPYD variants.
This puts them at significant risk of:
• Cardiovascular: myocardial ischemia, angina
• Gastrointestinal: gastrointestinal ulceration, bleeding, and intensive diarrhea
• Hematology: anemia, thrombocytopenia
• Psychiatric: disorientation, confusion, depression
• In severe cases, accelerated death
PGxOnco™ provides recommendations for >30 chemotherapeutics and ~100 traditionally cancer supportive drugs.
Clear, Color-Coded Results
Results are delivered in an easy-to-manage report, providing the relevant information to make more informed treatment decisions
Proceed With Caution
Normal Response Expected